Impact of GLP‐1 Receptor Agonists on Hidradenitis Suppurativa: A Cross‐Sectional Survey
International Journal of Dermatology · 2026-12 · 65 (12) · 2617-2619
DOI: 10.1111/ijd.70586 ↗Kurz gefasst
Leserbrief in der Zeitschrift International Journal of Dermatology, online erschienen am 16.07.2026. Verfasst von Elika D Javaheri und 3 weiteren Autor:innen. Beteiligte Einrichtung: Mayo Clinic Alix School of Medicine, Phoenix, Arizona, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 4 Literaturangaben. Gefördert von: Mayo Clinic Arizona Department of Dermatology Residency Program.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Mayo Clinic Alix School of Medicine, Phoenix, Arizona, USA.
- Department of Dermatology, Mayo Clinic, Scottsdale, Arizona, USA.
- Division of Clinical Trials and Biostatistics, Mayo Clinic, Scottsdale, Arizona, USA.
ORCID-Profile: Elika D Javaheri
Förderung
- Mayo Clinic Arizona Department of Dermatology Residency Program
Zitieren
APA
Javaheri, E. D., Godfrey, H., Yee, C., & Chen, S. X. (2026). Impact of GLP‐1 Receptor Agonists on Hidradenitis Suppurativa: A Cross‐Sectional Survey. International Journal of Dermatology, 65(12), 2617-2619. https://doi.org/10.1111/ijd.70586
Vancouver
Javaheri ED, Godfrey H, Yee C, Chen SX. Impact of GLP‐1 Receptor Agonists on Hidradenitis Suppurativa: A Cross‐Sectional Survey. International Journal of Dermatology. 2026;65(12):2617-2619. doi:10.1111/ijd.70586
BibTeX
@article{Javaheri2026,
author = {Javaheri, Elika D and Godfrey, Hannah and Yee, Claire and Chen, Stella X},
title = {Impact of GLP‐1 Receptor Agonists on Hidradenitis Suppurativa: A Cross‐Sectional Survey},
journal = {International Journal of Dermatology},
year = {2026},
volume = {65},
number = {12},
pages = {2617--2619},
doi = {10.1111/ijd.70586}
}
EUVIMED